This week we discussed aprocitentan, another endothelin receptor antagonist, this time being explored in the resistant hypertension arena - you know the #TenTweetNephJC drill, if you want a rapid catch up then here’s your place!
PRECISION Targeting in Resistant Hypertension
The PRECISION Visual Abstract
Is Aprocitentan effective in lowering BP in resistant hypertension? PRECISION trial answers it with a meticulous design. Checkout the VA by NSMC intern Sandhya Suresh which captures many elements of that meticulous design.